DIA/EFGCP/EMA Conference on How to Optimise Children’s Access to Innovative Medicines

United in the goal of increasing the availability of new medicines to paediatric patients, how can we leverage examples from past successes to overcome future barriers?

返回 Agenda

Networking Reception

Speaker(s)

Challenges and Opportunities/Solutions in Treatment of Neonatal Patients

Mark Turner, MD, PhD, MRCP, FFPM

University of Liverpool, United Kingdom

Chief Executive Officer of the c4c- Stichting (c4c-S) & Professor of Neonatology

DIA/EFGCP/EMA Conference on How to Optimise Children’s Access to Innovative Medicines

Networking Reception

Speaker(s)

Challenges and Opportunities/Solutions in Treatment of Neonatal Patients

获得信息并保持参与